Fibromyalgia treatment market
Fibromyalgia Treatment Market, (By Drug Class: Antidepressants, Antiepileptics, Muscle Relaxants, Analgesics, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
- Mar 2024
- CMI1691
- 176 Pages
- Excel & Pdf
- Pharmaceutical
Summary
N/A
Table of Content
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Class
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Pipeline Analysis
- Patent Litigations
- Reimbursement
- Patent Landscape (ANDA/NDA Intelligence)
- PEST Analysis
- Porter’s Analysis
- Market Dynamics
- Global Fibromyalgia Treatment Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the market
- Global Fibromyalgia Treatment Market, By Drug Class, 2019 – 2031, (USD BN)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Antidepressants
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Segment Trends
- Antiepileptics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Segment Trends
- Muscle Relaxants
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Analgesics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Overview
- Global Fibromyalgia Treatment Market, By Distribution Channel, 2019 – 2031, (USD BN)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 – 2031
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
- Overview
- Global Fibromyalgia Treatment Market, By Region, 2019 – 2031, (USD BN)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Regions, 2019–2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD BN)
- North Africa
- Central Africa
- South Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Market Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Market Strategies
- Allergan plc
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Market Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Market Strategies
- Aptinyx, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Market Strategies
- Prismic Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Market Strategies
- Innovative Med Concepts, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Market Strategies
- Intec Pharma Ltd
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Market Strategies
- Astellas Pharma Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Market Strategies
- Johnson & Johnson
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Market Strategies
- GSK
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Market Strategies
- AstraZeneca plc
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Market Strategies
- Bristol Myers Squibb
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Market Strategies
- Viatris
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Market Strategies
- Takeda Pharmaceutical Company Limited
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Market Strategies
- Amgen Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Market Strategies
- Sanofi
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Market Strategies
- Eli Lilly and Company
- Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
- References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
*Browse 32 market data tables and 35 figures on "Global Fibromyalgia Treatment Market” - forecast to 2031
Segmentation
Market Segmentation
- Drug Class:
- Antidepressants
- Antiepileptics
- Muscle Relaxants
- Analgesics
- Others
- Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Frequently Asked Questions -
What will be the CAGR of the fibromyalgia treatment market?
The CAGR of the fibromyalgia treatment market is projected to be 3.3% from 2024 to 2031.
What are the major factors driving the fibromyalgia treatment market growth?
Increasing research and development activities for the development of new therapies and approval and launch of novel fibromyalgia treatment drugs are the major factors driving the growth of the fibromyalgia treatment market.
What are the key factors hampering growth of the fibromyalgia treatment market?
Side effects of drugs and high treatment cost are the major factor hampering the growth of the fibromyalgia treatment market.
Which is the leading drug class in the fibromyalgia treatment market?
In terms of Drug Class, Antiepileptics is estimated to dominate the market revenue share 2024.
Which are the major players operating in the fibromyalgia treatment market?
Eli Lilly and Company, Pfizer Inc., Novartis AG, Allergan plc, Sun Pharmaceutical Industries Ltd., Aptinyx Inc., Prismic Pharmaceuticals Inc., Innovative Med Concepts Inc., Intec Pharma Ltd., Astellas Pharma Inc., Johnson & Johnson, GSK, AstraZeneca plc, Bristol Myers Squibb, Viatris, Takeda Pharmaceutical Company Limited, Amgen Inc., and Sanofi are the major players.
Which region will lead the fibromyalgia treatment market?
North America is expected to lead the fibromyalgia treatment market.